Merck & Co., Inc. (MRK) Uses Legal Threats To Silence Negative Advice About Zetia And Vytorin In Italy
7/7/2014 6:05:23 AM
In response to repeated legal threats, a public health doctor in Italy has withdrawn advice to curtail use of a controversial drug. The drug, ezetimibe, is a key ingredient in Zetia and Vytorin, which is manufactured by Merck . The cholesterol-lowering drug has been the subject of fierce controversy because it has never been shown to improve clinical outcomes. Despite the controversy, in 2013 the drugs had combined sales of more than $2.6 billion.
Help employers find you! Check out all the jobs and post your resume.
comments powered by